Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business & Finance
Discoverer of transrenal-DNA announces 2005-2006 strategic initiatives, goals
June 30th, 2005
Xenomics, Inc. (XNOM), a developer of medical DNA technologies, has announced the release of its strategic initiatives for 2005 and beyond. The report recaps major recent milestones in the company's development of a proprietary transrenal-DNA (Tr-DNA) platform to create a growing suite of advanced, noninvasive and accurate medical tests for a range of diseases and genetic conditions. It also outlines strategic goals for the coming year as the company pursues its biomedical research and business initiatives. "It is hard to describe the excitement that we are all experiencing at Xenomics as a result of a recent series of breakthroughs in our work,...
Source: Women's Health Weekly (2005-06-30)
|
